Harbert Fund Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Harbert Fund Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,175,913	Closed	-$1.92M	–	66
2025 Q1	$1.92M	Hold	5,175,913	–	–	2.17%	14
2024 Q4	$3.7M	Hold	5,175,913	–	–	1.92%	14
2024 Q3	$5.8M	Hold	5,175,913	–	–	3.43%	5
2024 Q2	$5.64M	Hold	5,175,913	–	–	4.01%	7
2024 Q1	$6.57M	Hold	5,175,913	–	–	4.52%	4
2023 Q4	$7.19M	Hold	5,175,913	–	–	4.93%	1
2023 Q3	$7.25M	Hold	5,175,913	–	–	5.17%	2
2023 Q2	$9.52M	Hold	5,175,913	–	–	5.34%	2
2023 Q1	$12.6M	Hold	5,175,913	–	–	8.31%	1
2022 Q4	$7.4M	Hold	5,175,913	–	–	5.93%	3
2022 Q3	$11.5M	Hold	5,175,913	–	–	6.13%	2
2022 Q2	$10.7M	Hold	5,175,913	–	–	5.21%	5
2022 Q1	$15M	Hold	5,175,913	–	–	6.29%	3
2021 Q4	$16.6M	Hold	5,175,913	–	–	4.19%	8
2021 Q3	$18.3M	Hold	5,175,913	–	–	6.51%	3
2021 Q2	$16.4M	Hold	5,175,913	–	–	9.16%	2
2021 Q1	$17.8M	Sell	5,175,913 -444,768	-8%	-$1.38M	8.4%	4
2020 Q4	$14.2M	Hold	5,620,681	–	–	10.73%	3
2020 Q3	$11.9M	Hold	5,620,681	–	–	14.49%	2
2020 Q2	$12.6M	Hold	5,620,681	–	–	14.34%	2
2020 Q1	$14.2M	Hold	5,620,681	–	–	23.77%	1
2019 Q4	$14.8M	Hold	5,620,681	–	–	19.75%	2
2019 Q3	$20.2M	Buy	5,620,681 +451,344	+9%	+$1.6M	30.1%	1
2019 Q2	$17.4M	Buy	5,169,337 +2,135,696	+70%	+$7.52M	25.49%	2
2019 Q1	$8.28M	Buy	3,033,641 +1,428,641	+89%	+$4.68M	8.14%	3
2018 Q4	$4.46M	Buy	+1,605,000	New	+$5.26M	4.55%	6

Other funds holding ENZ

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

KCM

Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Harbert Fund Advisors's ENZ Position: Q2 2025 in Review

Harbert Fund Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 5,175,913 shares — an estimated $1.92M sold.

Harbert Fund Advisors first reported a position in ENZ in Q4 2018 and held it in 26 quarters. The position peaked at $20.2M in Q3 2019. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

Harbert Fund Advisors reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
Harbert Fund Advisors sold 5,175,913 Enzo Biochem, Inc. shares in Q2 2025, an estimated $1.92M.
Harbert Fund Advisors first reported a position in Enzo Biochem, Inc. in Q4 2018 and held it in 26 quarters.
Harbert Fund Advisors's Enzo Biochem, Inc. position peaked at $20.2M in Q3 2019.
6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Harbert Fund Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.